SCHEMBL6603716

SCHEMBL6603716

CCc1nc(OC(N)=O)sc1C(=O)Nc1c(C)cc(C)cc1C

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 15/20 0.51
CISD2 Q8N5K1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608789 0.85 LCK (0.66) LCKCISD2
SCHEMBL1541226 0.82 LCK (0.71) LCKCISD2
SCHEMBL27562367 0.81 LCK (0.50) LCKCISD2
SCHEMBL773032 0.79 LCK (0.61) LCK
SCHEMBL27562374 0.79 LCK (0.50) LCK
SCHEMBL14568867 0.74 LCK (0.76) LCK
SCHEMBL7622222 0.74 LCK (0.60) LCK
SCHEMBL7629232 0.73 LCK (0.45) LCKCISD2
SCHEMBL6603764 0.73 LCK (0.56) LCK
SCHEMBL7631673 0.73 LCK (0.46) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169038-A4 CYCLIC PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2004-10-13 EP claimed
EP-1169038-A1 CYCLIC PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-01-09 EP claimed
WO-2000062778-A1 CYCLIC PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB CO. (US) 2000-10-26 WO claimed